Navigation Links
Data Show Medication Adherence is an Important Factor in the Treatment of Postmenopausal Osteoporosis
Date:9/13/2009

arantee of our ability to obtain or maintain patent protection for our products or product candidates. We cannot guarantee that we will be able to produce commercially successful products or maintain the commercial success of our existing products. Our stock price may be affected by actual or perceived market opportunity, competitive position, and success or failure of our products or product candidates. Further, the discovery of significant problems with a product similar to one of our products that implicate an entire class of products could have a material adverse effect on sales of the affected products and on our business and results of operations.

The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration (FDA), and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Only the FDA can determine whether the product candidates are safe and effective for the use(s) being investigated. Further, the scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration (FDA) for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses. Only the FDA can determine whether the products are safe and effective for these uses. Healthcare professionals should refer to and rely upon the FDA-approved labeling for the products, and not the information discussed in this news release.

(i) Do T, et al. Impact of Treatment Satisfaction (Perceived Benefits, Convenience, Side Effects) on Persistence with Postmenopausal Osteoporosis (PMO) T
'/>"/>

SOURCE Amgen Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Research: Popular Diabetes Medications Associated with Increase in Bone Fractures
2. New Study Evaluating the ADHD Medication VYVANSE(R) (lisdexamfetamine dimesylate) CII Demonstrated No Change in the Pharmacokinetic Profile of VYVANSE When Coadministered with Prilosec OTC(R) 40 mg (20 mg X 2), a Commonly Used Proton Pump Inhibitor (PPI)
3. VIDEO from Medialink and the Epilepsy Foundation: New Study Suggests Different Versions of the Same Epilepsy Medication Can Be Harmful
4. New Studies Show Popular Heartburn Medications Moderate the Effect of Taking Widely Prescribed Heart Drug
5. Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms
6. Addrenex Pharmaceuticals Reports Positive Results in Second Phase 3 Study of ADHD Medication
7. CareHeres Electronic Medication System Proves 100 Percent Effective in Response to Recall
8. American Lung Association Study to be Published in the New England Journal of Medicine Finds Prescription Heartburn Medication Does Not Control Asthma Symptoms as Previously Thought
9. Parkinsons Disease Medication Triggers Destructive Behaviors
10. Aching Back? Cholesterol Medication Might Help
11. Thomson Reuters Study Finds Sharp Increase in Use of Sleep Medications by Young Adults
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... 14 Gibraltar Associates, a leading ... and domestic communications and issues management, today ... with PositiveID Corporation (Nasdaq: PSID ) ... agency of record. Gibraltar Associates will conduct ... advise the Company on its public relations ...
(Date:12/14/2009)... -- VION PHARMACEUTICALS, INC. (OTC Bulletin ... a complete response letter from the U.S. Food ... Drug Application ("NDA") for Onrigin(TM) (laromustine) injection submitted ... the FDA cannot approve the Company,s NDA in ... remaining issues. ,, Alan Kessman, Chief Executive Officer, ...
(Date:12/14/2009)... HELSINKI, Dec. 14 Cancer patients in ... with the introduction of RapidArc® radiotherapy technology from ... at the only private radiotherapy clinic in the ... are using this fast and precise form of ... and cancers of the abdomen and prostate. ,, ...
Breaking Medicine Technology:Gibraltar Associates Named Agency of Record for Health Information and Diagnostic Provider PositiveID Corporation 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 2Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration 3Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 2Cancer Patients in Finland Gain Access to Advanced RapidArc Radiotherapy Treatments 3Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 1Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 2Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 3Study Finds Racial Inequalities Cost U S Health System Over 2450 Billion a Year 57473 4Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 1Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 2Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 3Cowen Healthcare Royalty Partners Establishes Strategic Advisory Board 14117 4Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 1Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 2Intarcia Therapeutics Inc Commences Enrollment of ITCA 650 Phase 2 Study in Type 2 Diabetes 14115 3
(Date:12/15/2009)... January 1, 2010 Oregon will require that certain businesses with ... automated external defibrillator (AED) readily available. Fire and rescue personnel ... AED is a good investment. , ... ... 1, 2010 Oregon will require that certain businesses with large ...
(Date:12/15/2009)... the Dec. 15 issue of the Journal of ... obese increases the risk for developing obstructive sleep apnea ... , Results indicate that the risk of OSA ... increased 3.5 fold with each standard-deviation increase in body ... did not significantly increase with increasing BMI among younger ...
(Date:12/14/2009)... BROOK, Ill., Dec. 15 In today,s ... larger role than ever. Now the University HealthSystem ... resources, Value Analysis: Achieving Cost Efficiencies in ... in these complex environments. These new materials, developed ... the field, provide a practical guide to planning, ...
(Date:12/14/2009)... ABBOTT PARK, Ill. and HOLLYWOOD, Fla., Dec. ... ABT ) announced today a definitive agreement ... LIMS ), a leading provider of laboratory ... in cash. ,, The acquisition strengthens ... market, providing advanced web-based applications to help ...
(Date:12/14/2009)... Incorporated announced today that it has priced $400 ... a coupon of 6.9%. The notes will be ... 6.984%. The company anticipates using the proceeds from ... purposes. ,, Commenting on the pricing of the ... Officer Kriss Cloninger III commented: "This debt issuance ...
Breaking Medicine News(10 mins):Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3Health News:Obesity increases the risk for obstructive sleep apnea in adolescents, but not in younger children 2Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4
... profound effect on the psychological behavior in adulthood. It has ... full term but weighing below 5.5 lbs are at 50% ... same after taking into consideration various factors likes father’s social ... has been unclear whether the effect of low birth weight ...
... Vaccines for prophylaxis are well known. Famous vaccines include ... etc.; Therapeutic vaccines to cure a condition are more ... include the ones against HIV and hepatitis. The therapeutic ... combat an infectious agent, such as a virus. Now ...
... of autistic children have led to a fear in the ... autistic epidemic. However a recent report, which was published in ... this is not true. The report points out to certain ... ,The study had pointed out that recent changes in ...
... in the International Journal of Epidemiology has implicated maternal ... arthritis and other inflammatory polyarthropathies(RA&IP )during the first ... chronic inflammatory disorder that leads to the destruction of ... of the joints. Several studies have shown that maternal ...
... used for prevention of pregnancy for decades and more recently ... that wearing a condom during intercourse may not give good ... and syphilis. ,There has been a rise recently in ... the news may come as a surprise to many. Current ...
... at risk of having a pre-term baby may perhaps will ... // that pomegranate juice can prevent brain injury the fetus ... flow in case of a pre-term delivery., ,Pomegranate juice ... potential property of neuroprotection and anti-aging effects. ,Researchers ...
Other Medicine News:Health News:Is low birth weight related to psychological distress in adulthood? 2Health News:Understanding Chronic Infections May Help in Developing Therapeutic Vaccines 2Health News:Condoms May not be safe Enough 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: